Streetbeat News

BICX

BioCorRx Inc

https://www.biocorrx.com/

CEO

Brady Granier

Employees

Industry

General Medical and Surgical Hospitals

Open

0.36

Mkt cap

4.6M

Volume

100

High

0.36

P/E Ratio

-0.75

52-wk high

1.50

Low

0.36

Div yield

N/A

52-wk low

0.28

Insiders at OPKO Health, BioCorRx, Coeptis Therapeutics, and Collective Audience have recently purchased shares of their respective companies, signaling confidence in their prospects. OPKO Health's Vice Chairman and CTO acquired 150,000 shares, while BioCorRx's Interim President bought 3,126 shares. Coeptis Therapeutics' CFO purchased 5,000 shares, and Collective Audience's CEO acquired 20,000 shares. These transactions come amidst various company developments, including OPKO Health's private offering, BioCorRx's stock decline, Coeptis Therapeutics' shareholder letter, and Collective Audience's new COO appointment.

Portfolio Pulse from Avi Kapoor

January 18, 2024 | 1:55 pm

Insiders at BioCorRx Inc. (OTC:BICX), Rezolute, Inc. (NASDAQ:RZLT), and Cadiz Inc. (NASDAQ:CDZI) have recently made significant share purchases. BioCorRx Director Joseph J Galligan acquired 184,780 shares, Rezolute's Chief Medical Officer Brian Kenneth Roberts bought 5,000 shares, and Cadiz's 10% owner Heerema International Group Services SA purchased 200,000 shares. These transactions indicate the insiders' confidence in their respective companies' prospects.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 12:59 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.